Literature DB >> 11316800

Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C.

U Friedrich1, A M Blom, B Dahlbäck, B O Villoutreix.   

Abstract

Human activated protein C (APC) is a key component of a natural anticoagulant system that regulates blood coagulation. In vivo, the catalytic activity of APC is regulated by two serpins, alpha1-antitrypsin and the protein C inhibitor (PCI), the inhibition by the latter being stimulated by heparin. We have identified a heparin-binding site in the serine protease domain of APC and characterized the energetic basis of the interaction with heparin. According to the counter-ion condensation theory, the binding of heparin to APC is 66% ionic in nature and comprises four to six net ionic interactions. To localize the heparin-binding site, five recombinant APC variants containing amino acid exchanges in loops 37, 60, and 70 (chymotrypsinogen numbering) were created. As demonstrated by surface plasmon resonance, reduction of the electropositive character of loops 37 and 60 resulted in complete loss of heparin binding. The functional consequence was loss in heparin-induced stimulation of APC inhibition by PCI, whereas the PCI-induced APC inhibition in the absence of heparin was enhanced. Presumably, the former observations were due to the inability of heparin to bridge some APC mutants to PCI, whereas the increased inhibition of certain APC variants by PCI in the absence of heparin was due to reduced repulsion between the enzymes and the serpin. The heparin-binding site of APC was also shown to interact with heparan sulfate, albeit with lower affinity. In conclusion, we have characterized and spatially localized the functionally important heparin/heparan sulfate-binding site of APC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316800     DOI: 10.1074/jbc.M011567200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  An update on activated protein C (xigris) in the management of sepsis.

Authors:  Cesar Alaniz
Journal:  P T       Date:  2010-09

2.  Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate.

Authors:  Rachel E Miller; Alan J Grodzinsky; Kiersten Cummings; Anna H K Plaas; Ada A Cole; Richard T Lee; Parth Patwari
Journal:  Arthritis Rheum       Date:  2010-12

3.  Heparan sulfate proteoglycans mediate factor XIIa binding to the cell surface.

Authors:  Lukasz Wujak; Miroslava Didiasova; Dariusz Zakrzewicz; Helena Frey; Liliana Schaefer; Malgorzata Wygrecka
Journal:  J Biol Chem       Date:  2015-01-14       Impact factor: 5.157

Review 4.  Activated protein C action in inflammation.

Authors:  Pranita P Sarangi; Hyun-wook Lee; Minsoo Kim
Journal:  Br J Haematol       Date:  2009-12-08       Impact factor: 6.998

5.  A novel heparin-dependent inhibitor of activated protein C that potentiates consumptive coagulopathy in Russell's viper envenomation.

Authors:  An-Chun Cheng; Hua-Lin Wu; Guey-Yueh Shi; Inn-Ho Tsai
Journal:  J Biol Chem       Date:  2012-03-13       Impact factor: 5.157

Review 6.  Heparin-binding domains in vascular biology.

Authors:  Eva M Muñoz; Robert J Linhardt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-01       Impact factor: 8.311

Review 7.  Exosites in the substrate specificity of blood coagulation reactions.

Authors:  P E Bock; P Panizzi; I M A Verhamme
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

8.  Protective effects of non-anticoagulant activated protein C variant (D36A/L38D/A39V) in a murine model of ischaemic stroke.

Authors:  Anna P Andreou; Maria Efthymiou; Yao Yu; Helena R Watts; Faruq H Noormohamed; Daqing Ma; David A Lane; James T B Crawley
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.